Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease

Therapeutics and Clinical Risk Management

Volumn 3, Issue 6, 2007, Pages 999-1001

  Bellia, Chiara ^a   Bivona, Giulia ^a   Scazzone, Concetta ^a   Ciaccio, Marcello ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cardiovascular disease; Homocysteine; Metabolic syndrome

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBSERVATIONAL STUDY; PREDICTION; PREVALENCE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

EID: 38049165775     PISSN: 11766336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bonaa KH, Njolstad I, Ueland PM, et al. 2006. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med, 354:1578-88.
2. Cranford LS. 2003. Diagnosis, prevention and intervention for the metabolic syndrome. Am J Cardiol, 92:35-42.
3. Danker R, Chetrit A, Lubin F, et al. 2004. Life-style habits and homocysteine levels in an elderly population. Aging Clin Exp Res, 16:437-42.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP), 2001. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP III). JAMA, 285:2486-97.
5. Hajer GR, van der Graaf Y, Olijhoek JK, et al. 2007. Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart, 93:216-20.
6. Lonn E, Held C, Arnold JM, et al. 2006. Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients; the Heart Outcomes Prevention Evaluation (HOPE)-2 trial. Can J Cardiol, 22:47-53.
7. Malinow MR, Bostom AG, Krauss RM. 1999. Homocyst(e)ine, diet, and cardiovascular diseases. A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation, 99: 178-82.
8. Ninomiya JK, L'Italien G, Criqui MH, et al. 2004. Association of the Metabolic Syndrome with history of myocardial infarction and stroke in the Third National Health and Nutritional Examination Survey. Circulation, 109:42-6.
9. Siragusa S, Malato A, Cigna V, et al. 2007. The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins. Thromb Res, in press.
10. Virtanen JK, Voutilainen S, Alfthan G, et al. 2005. Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors: the Kuopio Ischaemic Heart Disease Risk Factors (KIHD) Study. J Intl Med, 257:255-62.